ReviewCurrent cancer drug targets2014

Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.

Q Ping Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.